Nexlizet (bempedoic acid and ezetimibe), 180ng/18mg, 30 tablets, Rx only, Manufactured for: Esperion Therapeutics, Inc, Ann Arbor, MI 48108, NDC 72426-818-03
Published September 13, 2023 · Recall initiated: August 16, 2023
Summary
FDA records drug Class III recall D-1143-2023, published September 13, 2023 and initiated August 16, 2023. Recalling firm: Esperion; Status: Completed; Reported quantity: 45,240 bottles; Lot: Lot# 1904872, Exp 1/31/2025; 1950377, Exp 6/30/2025. Class III means the product is not likely to cause adverse health consequences.
Status when published: Completed — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed dissolution specifications: below specification results at stability 12-month
What to do
Voluntary: Firm initiated · Letter
Get an email if NEXLIZET has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- NEXLIZET
- Manufacturer
- Esperion
- Distributor
- Nationwide USA
- Lot
- Lot# 1904872, Exp 1/31/2025; 1950377, Exp 6/30/2025
- Risk classification
- Class III
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDANEXLIZET (bempedoic acid and ezetimibe) tablets, 180 mg/10 mg, 30-count bottle, Rx only, Manufactured for:April 24, 2024
- FDAMilrinone Lactate Injection, USP 20mg/20 mL (1mg/mL), packaged in 10 x 20 mL vials per carton, NDCSeptember 13, 2023
- FDAFosfomycin Tromethamine Granules for Oral Solution, 3 g single- dose sachet, Rx only, Manufactured by: AlkemSeptember 13, 2023
- FDAOlympus Bronchovideoscope, Models BF-3C160.September 6, 2023
- FDAOlympus Tracheal Intubation Fiberscope, Models LF-P & LF-V.September 6, 2023
- FDAOculus Pentacam AXL , Ref 70100, CE 0123September 6, 2023
Questions about this recall
Was Nexlizet (bempedoic acid and ezetimibe), 180ng/18mg, 30 tablets, Rx only, Manufactured for: Esperion Therapeutics, Inc, Ann Arbor, MI 48108, NDC 72426-818-03 recalled?
Yes. FDA published recall D-1143-2023 on September 13, 2023. Reported hazard: Failed dissolution specifications: below specification results at stability 12-month
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: NEXLIZET.